Li-Xia Yan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Li-Xia Yan has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Li-Jian Chen
Institute of Analytical Food Safety, School of Food Science and Technology, Jiangnan University, Wuxi 214122, China
4 shared publications - Xiu-Ping Yan
Institute of Analytical Food Safety, School of Food Science and Technology, Jiangnan University, Wuxi 214122, China
4 shared publications Xu Zhao
4 shared publicationsXiao-Dong Huang
Technology Innovation Center of Special Food, State Administration for Market Regulation (TISF), Wuxi, 214100, China
3 shared publications- Yi Zhang
State Key Laboratory of Food Science and Resources, School of Food Science and Technology, Jiangnan University, Wuxi 214122, China
3 shared publications Jie Zhou
School of Biotechnology, Jiangnan University, Wuxi, 214122, China
2 shared publications
Latest Publications
- Open Access
- 26 March 2026
- Published by Elsevier in Advanced Sensor and Energy Materials
- Vol. 5 (2)
Persistent luminescence nanoparticles in phototheranostics: Recent progress and translational outlook
- 26 March 2026
- Published by Elsevier in Advanced Sensor and Energy Materials
- Vol. 5 (2)
Open AccessPersistent luminescence nanoparticles in phototheranostics: Recent progress and translational outlook
- Top Cited Papers
- 5 January 2026
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 297, 118373
Copper selenide nanomaterial mediated light-driven RPA-SDA cascade amplification combined with photothermal test strips for methicillin-resistance gene mecA detection
- 5 January 2026
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 297, 118373
Top Cited PapersCopper selenide nanomaterial mediated light-driven RPA-SDA cascade amplification combined with photothermal test strips for methicillin-resistance gene mecA detection
- 7 May 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (12) , 3229-3237
Self-evolving persistent luminescence nanoprobes for autofluorescence-free ratiometric imaging and on-demand enhanced chemodynamic therapy of pulmonary metastatic tumors
Precise imaging-guided therapy of a pulmonary metastasis tumor is of great significance for tumor management and prognosis. Persistent luminescence nanoparticles (PLNPs) are promising probes due to their in situ excitation-free and low-background imaging characteristics. However, most of the PLNP-based probes cannot intelligently distinguish between normal and tumor tissues or balance the needs of targeted accumulation and rapid metabolism, resulting in false positive signals and potential side effects. Besides, the luminescence intensity of single-emissive PLNPs is affected by external factors. Herein, we report a self-evolving double-emissive PLNP-based nanoprobe ZGMC@ZGC-TAT for pulmonary metastatic tumor imaging and therapy. Acid-degradable green-emitting PLNPs (ZGMC) with good afterglow performance and therapeutic potential are synthesized by systematic optimization of dopants. Ultra-small red-emitting PLNPs (ZGC) are then prepared as imaging and reference probes. The two PLNPs are finally covalently coupled and further modified with a cell-penetrating peptide (TAT) to obtain ZGMC@ZGC-TAT. Dual emission ensures a stable luminescence ratio (I700/I537) independent of probe concentration, test voltage and time gate. ZGMC degrades and phosphorescence disappears in a tumor microenvironment (TME), resulting in an increase in I700/I537, thus enabling tumor-specific ratiometric imaging. Cu2+ and Mn2+ released by ZGMC degradation achieve GSH depletion and enhance CDT, effectively inhibiting tumor cell proliferation. Meanwhile, the size of ZGMC@ZGC-TAT decreases sharply, and the resulting ZGC-TAT further causes nuclear pyknosis and quickly clear metabolism. The developed ZGMC@ZGC-TAT turns non-targeted lung aggregation of nanomaterials into a unique advantage, and integrates TME-triggered phosphorescence and size self-evolution, and on-demand therapeutic functions, showing outstanding prospects in precise imaging and efficient treatment of pulmonary metastatic tumors.
- 7 May 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (12) , 3229-3237
Self-evolving persistent luminescence nanoprobes for autofluorescence-free ratiometric imaging and on-demand enhanced chemodynamic therapy of pulmonary metastatic tumors
Precise imaging-guided therapy of a pulmonary metastasis tumor is of great significance for tumor management and prognosis. Persistent luminescence nanoparticles (PLNPs) are promising probes due to their in situ excitation-free and low-background imaging characteristics. However, most of the PLNP-based probes cannot intelligently distinguish between normal and tumor tissues or balance the needs of targeted accumulation and rapid metabolism, resulting in false positive signals and potential side effects. Besides, the luminescence intensity of single-emissive PLNPs is affected by external factors. Herein, we report a self-evolving double-emissive PLNP-based nanoprobe ZGMC@ZGC-TAT for pulmonary metastatic tumor imaging and therapy. Acid-degradable green-emitting PLNPs (ZGMC) with good afterglow performance and therapeutic potential are synthesized by systematic optimization of dopants. Ultra-small red-emitting PLNPs (ZGC) are then prepared as imaging and reference probes. The two PLNPs are finally covalently coupled and further modified with a cell-penetrating peptide (TAT) to obtain ZGMC@ZGC-TAT. Dual emission ensures a stable luminescence ratio (I700/I537) independent of probe concentration, test voltage and time gate. ZGMC degrades and phosphorescence disappears in a tumor microenvironment (TME), resulting in an increase in I700/I537, thus enabling tumor-specific ratiometric imaging. Cu2+ and Mn2+ released by ZGMC degradation achieve GSH depletion and enhance CDT, effectively inhibiting tumor cell proliferation. Meanwhile, the size of ZGMC@ZGC-TAT decreases sharply, and the resulting ZGC-TAT further causes nuclear pyknosis and quickly clear metabolism. The developed ZGMC@ZGC-TAT turns non-targeted lung aggregation of nanomaterials into a unique advantage, and integrates TME-triggered phosphorescence and size self-evolution, and on-demand therapeutic functions, showing outstanding prospects in precise imaging and efficient treatment of pulmonary metastatic tumors.
- 6 February 2024
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 662, 11-18
Size-independent boosting of near-infrared persistent luminescence in nano-phosphors via a magnesium doping strategy
- 6 February 2024
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 662, 11-18
Size-independent boosting of near-infrared persistent luminescence in nano-phosphors via a magnesium doping strategy